SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
All-trans retinoic acid (ATRA) is a well-known ligand for RARγ. It directly binds to RARγ, promoting its activation and subsequent modulation of gene expression. ATRA functions by inducing a conformational change in the receptor, leading to the recruitment of coactivators and initiation of downstream signaling pathways, such as those involved in cell differentiation and apoptosis. | ||||||
AM 580 | 102121-60-8 | sc-203505 sc-203505A | 5 mg 25 mg | $99.00 $390.00 | 2 | |
AM 580 acts as a potent RAR gamma agonist, exhibiting a unique ability to stabilize receptor conformations through specific electrostatic interactions and hydrophobic contacts. This compound enhances the receptor's affinity for retinoic acid, promoting distinct transcriptional responses. Its reaction kinetics demonstrate a fast binding rate, coupled with a prolonged residence time, allowing for sustained modulation of gene expression and cellular signaling pathways. | ||||||
9-cis-Retinoic acid | 5300-03-8 | sc-205589 sc-205589B sc-205589C sc-205589D sc-205589A | 1 mg 25 mg 250 mg 500 mg 5 mg | $71.00 $424.00 $3121.00 $5722.00 $148.00 | 10 | |
9-cis-Retinoic acid functions as a selective RAR gamma agonist, characterized by its ability to induce conformational changes in the receptor through unique hydrogen bonding and van der Waals interactions. This compound facilitates the recruitment of coactivators, enhancing transcriptional activity. Its dynamic binding profile showcases a rapid association with the receptor, followed by a gradual dissociation, which supports prolonged regulatory effects on gene expression and cellular processes. | ||||||
Adapalene | 106685-40-9 | sc-203803 sc-203803A | 10 mg 50 mg | $66.00 $332.00 | 2 | |
Adapalene acts as a selective RAR gamma modulator, exhibiting distinct molecular interactions that stabilize the receptor-ligand complex. Its unique structure allows for specific hydrophobic interactions and π-π stacking with aromatic residues, promoting a robust binding affinity. The compound's kinetic profile reveals a fast initial binding phase, followed by a slower release, which may influence downstream signaling pathways and gene regulatory mechanisms, enhancing its functional versatility. | ||||||
TTNPB | 71441-28-6 | sc-203303 sc-203303A sc-203303B | 10 mg 25 mg 50 mg | $210.00 $347.00 $640.00 | 20 | |
The synthetic retinoid TTNPB (4-[(E)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl]benzoic acid) is another potent RARγ activator. It acts by binding to RARγ and facilitating its interaction with retinoid X receptors (RXRs), forming heterodimers that regulate target gene expression. | ||||||
CD 1530 | 107430-66-0 | sc-203871 sc-203871A | 10 mg 50 mg | $208.00 $832.00 | ||
CD 1530 functions as a selective RAR gamma modulator, characterized by its ability to engage in unique electrostatic interactions with receptor domains. This compound exhibits a distinctive conformational flexibility, allowing it to adapt to various binding sites. Its reaction kinetics demonstrate a biphasic binding pattern, facilitating prolonged receptor activation. Additionally, CD 1530's hydrophilic and lipophilic balance enhances its solubility, influencing its distribution and interaction dynamics within cellular environments. | ||||||
AC 261066 | 870773-76-5 | sc-361098 sc-361098A | 10 mg 50 mg | $175.00 $709.00 | ||
AC261066 is a synthetic RARγ-selective agonist that enhances the transcriptional activity of RARγ. Through its selective binding to RARγ, AC261066 influences gene expression patterns associated with cellular differentiation and homeostasis. The activation of RARγ by AC261066 is integral to regulating diverse cellular processes, ultimately impacting the fate and function of target cells in a context-specific manner. | ||||||
Docosa-4Z,7Z,10Z,13Z,16Z,19Z-hexaenoic Acid (22:6, n-3) | 6217-54-5 | sc-200768 sc-200768A sc-200768B sc-200768C sc-200768D | 100 mg 1 g 10 g 50 g 100 g | $94.00 $210.00 $1779.00 $8021.00 $16657.00 | 11 | |
Docosa-4Z,7Z,10Z,13Z,16Z,19Z-hexaenoic Acid acts as a potent RAR gamma modulator, showcasing remarkable affinity for specific receptor conformations. Its unique polyunsaturated structure enables intricate molecular interactions, promoting diverse signaling pathways. The compound's dynamic molecular flexibility allows for rapid conformational changes, optimizing binding efficiency. Furthermore, its amphipathic nature enhances membrane integration, influencing cellular uptake and receptor engagement. | ||||||
BMS 961 | 185629-22-5 | sc-362717 sc-362717A | 10 mg 50 mg | $306.00 $1020.00 | ||
BMS961, a synthetic retinoid, serves as an activator of RARγ by binding to the receptor and modulating its transcriptional activity. This leads to the regulation of genes associated with cell growth, differentiation, and apoptosis. BMS961's interaction with RARγ highlights its role in influencing specific signaling pathways that contribute to cellular homeostasis and the maintenance of tissue integrity. | ||||||
SR 11237 | 146670-40-8 | sc-296418 sc-296418A | 5 mg 50 mg | $211.00 $877.00 | ||
SR11237 is a selective RARγ agonist that plays a pivotal role in activating RARγ and modulating downstream signaling pathways. By binding to RARγ, SR11237 induces a cascade of events leading to the regulation of target genes involved in cellular differentiation and proliferation. The specific activation of RARγ by SR11237 underscores its potential as a chemical tool to dissect the intricate molecular mechanisms governed by RARγ in various cellular contexts. | ||||||